Equities

Jiangsu Nanfang Medical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Jiangsu Nanfang Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)6.79
  • Today's Change0.01 / 0.15%
  • Shares traded5.16m
  • 1 Year change+33.66%
  • Beta0.6987
Data delayed at least 15 minutes, as of Feb 10 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Rightongene Biotechnlgy Co Ltd191.78m-27.11m1.74bn401.00--1.93--9.08-0.4824-0.48243.4216.180.19541.291.14478,253.60-4.052.48-4.252.6770.6169.35-20.737.6013.93--0.002816.94-6.16-1.05-298.78---6.04--
AVE Science & Technology Co Ltd221.12m26.95m1.96bn503.0072.593.77--8.850.39630.39633.257.620.37962.0940.74439,603.904.635.205.195.8755.9857.4912.1912.484.47--0.054732.921.501.376.07-14.68-31.29--
Jiangsu Nanfang Medical Co Ltd594.86m-202.28m1.96bn850.00--7.72--3.30-0.6998-0.69982.060.880.53052.604.50699,834.10-18.06-4.62-51.29-9.50-5.0015.52-34.03-8.290.2557-6.480.6396--0.41994.15-29.34---10.48--
Suzhou Iron Technology Co Ltd381.50m5.23m2.02bn680.00331.772.60--5.300.0790.0795.1010.060.28222.231.50--0.43664.750.71547.3443.1053.911.5514.711.201.290.213331.78-10.522.22-173.52------
Shanghai Rendu Biotechnology Co Ltd165.86m-5.47m2.14bn335.00--2.33--12.90-0.1374-0.13744.1422.920.16621.622.93495,112.60-0.54824.37-0.58754.9176.4673.71-3.3012.6113.50--0.004711.167.8712.33-194.59---28.11--
Guangzhou LBP Medicine Scnc&Tech Co Ltd371.03m-19.11m2.64bn796.00--2.15--7.11-0.2042-0.20423.9713.100.27611.551.71466,121.80-1.493.50-1.553.7863.0372.02-5.419.797.80--0.011832.69-5.335.80-46.85-22.05-7.83--
Guangzhou Jet Bio-Filtration Co Ltd566.02m79.32m2.65bn1.08k35.122.14--4.670.53670.53673.758.810.3352.654.37523,125.404.817.565.108.3341.0736.8514.3516.266.469.350.233421.0320.6317.68107.511.7614.94-27.21
Jiangsu Cowin Biotech Co Ltd167.17m-137.72m2.87bn833.00--2.06--17.14-1.24-1.241.5112.360.10381.812.52200,679.40-8.912.79-9.422.9745.1568.50-85.8811.4713.54--0.015632.07-26.5411.23-86.25--34.36--
Maider Medical Industry Equipment Co Ltd279.92m-18.77m2.90bn657.00--3.60--10.36-0.1053-0.10531.684.850.2491.072.08426,058.40-3.345.79-4.306.8634.6849.32-13.4016.231.91--0.070563.92-42.775.58-120.02--22.08--
Data as of Feb 10 2026. Currency figures normalised to Jiangsu Nanfang Medical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
New China Fund Management Co., Ltd.as of 30 Jun 202546.50k0.02%
Western Leadbank Fund Management Co., Ltdas of 30 Jun 202517.00k0.01%
Springs Fund Management Co. Ltd.as of 30 Jun 20250.000.00%
China Asset Management Co., Ltd.as of 30 Jun 20250.000.00%
Lion Fund Management Co., Ltd.as of 30 Jun 20250.000.00%
JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 20250.000.00%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20250.000.00%
CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 20250.000.00%
More ▼
Data from 30 Jun 2025 - 30 Nov 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.